CareDx Inc (CareDx) is a diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. Its products include AlloSure, AlloMap, Qtype, Olerup SSP and SBT, Trusight, AlloSeq cfDNA, HeartCare, KidneyCare, Ottr Organ, Ottr Cellular, XynQAPI, TxAccess, XynCare, AlloCare, AlloCell and AlloSeq HCT. The company provides laboratory products along the pre and post-transplant testing continuum including human leukocyte antigen typing kits and testing solutions. CareDx offers novel surveillance management solutions to transform long-term patient care in transplantation. Its services also include digital transplant solutions, cell transplant therapy, pharma services, patient care management, and others. The company operates in the US, Sweden, and Australia. CareDx is headquartered in South San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CareDx Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- CareDx Inc Company Overview
- CareDx Inc Company Snapshot
- CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- CareDx Inc - Pipeline Analysis Overview
- CareDx Inc - Key Facts
- CareDx Inc - Major Products and Services
- CareDx Inc Pipeline Products by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc Pipeline Products Overview
- AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool
- AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool Product Overview
- AiKidney
- AiKidney Product Overview
- AlloHeme Liver
- AlloHeme Liver Product Overview
- AlloHeme Liver Clinical Trial
- AlloID
- AlloID Product Overview
- AlloID Clinical Trial
- AlloMap Liver
- AlloMap Liver Product Overview
- AlloSeq BMT
- AlloSeq BMT Product Overview
- AlloSure - BKV-Associated Nephropathy (BKVAN)
- AlloSure - BKV-Associated Nephropathy (BKVAN) Product Overview
- AlloSure Liver
- AlloSure Liver Product Overview
- Clinical Decision Support Tool
- Clinical Decision Support Tool Product Overview
- Diagnostic Test - Crohn's Disease
- Diagnostic Test - Crohn's Disease Product Overview
- Diagnostic Test - Multiple Sclerosis
- Diagnostic Test - Multiple Sclerosis Product Overview
- Diagnostic Test - Rheumatoid Arthritis
- Diagnostic Test - Rheumatoid Arthritis Product Overview
- Diagnostic Test - Sjogren's Syndrome
- Diagnostic Test - Sjogren's Syndrome Product Overview
- Diagnostic Test - Systemic Lupus Erythematosus
- Diagnostic Test - Systemic Lupus Erythematosus Product Overview
- HistoMap
- HistoMap Product Overview
- HistoMap Clinical Trial
- HistoMap Liver
- HistoMap Liver Product Overview
- Post Transplant Management-Lung Transplant
- Post Transplant Management-Lung Transplant Product Overview
- UroMap
- UroMap Product Overview
- CareDx Inc - Key Competitors
- CareDx Inc - Key Employees
- CareDx Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- CareDx Inc, Recent Developments
- May 29, 2024: Caredx Reiterates Position That It Does Not Infringe The ‘544 Patent, Injunction Motion Is Irrelevant
- May 16, 2024: Landmark Study Shows CareDx’s Heartcare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
- Apr 16, 2024: CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
- Apr 09, 2024: CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
- Feb 27, 2024: Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests
- Feb 21, 2024: CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
- Feb 21, 2024: CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
- Jan 26, 2024: CareDx Issues Statement in Patent Infringement Case
- Jan 11, 2024: Caredx Adds to Allosure Kidney and Heartcare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
- Dec 19, 2023: CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- CareDx Inc Pipeline Products by Equipment Type
- CareDx Inc Pipeline Products by Indication
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc, Key Facts
- CareDx Inc, Major Products and Services
- CareDx Inc Number of Pipeline Products by Development Stage
- CareDx Inc Pipeline Products Summary by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
- CareDx Inc Ongoing Clinical Trials Summary
- AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool - Product Status
- AI-Enabled Cardiac Allograft Vasculopathy (CAV) Scoring Tool - Product Description
- AiKidney - Product Status
- AiKidney - Product Description
- AlloHeme Liver - Product Status
- AlloHeme Liver - Product Description
- AlloHeme Liver - AlloSure Lung Assessment and Metagenomics Outcomes Study
- AlloHeme Liver - Assessment of Chimerism and Relapse Post Bone Marrow/HCT Transplant Using AlloHeme Test (ACROBAT)
- AlloID - Product Status
- AlloID - Product Description
- AlloID - AlloSure Lung Assessment and Metagenomics Outcomes Study
- AlloMap Liver - Product Status
- AlloMap Liver - Product Description
- AlloSeq BMT - Product Status
- AlloSeq BMT - Product Description
- AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Status
- AlloSure - BKV-Associated Nephropathy (BKVAN) - Product Description
- AlloSure Liver - Product Status
- AlloSure Liver - Product Description
- Clinical Decision Support Tool - Product Status
- Clinical Decision Support Tool - Product Description
- Diagnostic Test - Crohn's Disease - Product Status
- Diagnostic Test - Crohn's Disease - Product Description
- Diagnostic Test - Multiple Sclerosis - Product Status
- Diagnostic Test - Multiple Sclerosis - Product Description
- Diagnostic Test - Rheumatoid Arthritis - Product Status
- Diagnostic Test - Rheumatoid Arthritis - Product Description
- Diagnostic Test - Sjogren's Syndrome - Product Status
- Diagnostic Test - Sjogren's Syndrome - Product Description
- Diagnostic Test - Systemic Lupus Erythematosus - Product Status
- Diagnostic Test - Systemic Lupus Erythematosus - Product Description
- HistoMap - Product Status
- HistoMap - Product Description
- HistoMap - AlloSure Lung Assessment and Metagenomics Outcomes Study
- HistoMap Liver - Product Status
- HistoMap Liver - Product Description
- Post Transplant Management-Lung Transplant - Product Status
- Post Transplant Management-Lung Transplant - Product Description
- UroMap - Product Status
- UroMap - Product Description
- CareDx Inc, Key Employees
- CareDx Inc, Subsidiaries
- Glossary
- CareDx Inc Pipeline Products by Equipment Type
- CareDx Inc Pipeline Products by Development Stage
- CareDx Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Qiagen NV
- Eurofins Viracor Inc
- Omixon Ltd
- Natera Inc
- Immucor Inc
- Genome Diagnostics BV
- Thermo Fisher Scientific Inc
